Predictions
Inovio Pharma
Start price
Target price
Perf. (%)
€9.50
28.01.21
28.01.21
€14.00
23.16%
04.02.21
04.02.21
Risky Investment
High risks for its business
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€5.64
27.01.21
27.01.21
€8.00
27.01.22
27.01.22
9.75%
28.09.21
28.09.21
Could be worthwhile Investment >10% per year
Supernus Pharmaceuticals
Start price
Target price
Perf. (%)
€25.20
25.01.21
25.01.21
€28.00
25.01.22
25.01.22
3.97%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€173.98
25.01.21
25.01.21
€250.00
25.01.22
25.01.22
23.00%
17.01.22
17.01.22
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€22.08
25.01.21
25.01.21
€35.00
30.39%
08.02.21
08.02.21
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€63.50
24.01.21
24.01.21
-
24.01.22
24.01.22
-15.72%
11.03.21
11.03.21
Could be worthwhile Investment >10% per year
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.36
23.01.21
23.01.21
€100.00
23.01.22
23.01.22
-77.10%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Advaxis Inc.
Start price
Target price
Perf. (%)
€0.62
23.01.21
23.01.21
€60.00
23.01.22
23.01.22
-81.94%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Arca Biopharma
Start price
Target price
Perf. (%)
€3.98
23.01.21
23.01.21
€30.00
23.01.22
23.01.22
-60.05%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.19
23.01.21
23.01.21
€20.00
23.01.22
23.01.22
-51.51%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Hexo Corp.
Start price
Target price
Perf. (%)
€75.60
23.01.21
23.01.21
-
23.01.22
23.01.22
-75.74%
08.11.21
08.11.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good culture
Future proof or reliable business model
Teligent Inc.
Start price
Target price
Perf. (%)
€0.99
23.01.21
23.01.21
-
23.01.22
23.01.22
-97.97%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Zosano Pharma Corp.
Start price
Target price
Perf. (%)
€31.33
23.01.21
23.01.21
-
23.01.22
23.01.22
-55.15%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.86
23.01.21
23.01.21
€3.00
23.01.22
23.01.22
-38.46%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Higher risks for its business
Purple Biotech Ltd. ADR
Start price
Target price
Perf. (%)
€3.52
21.01.21
21.01.21
€60.00
21.01.23
21.01.23
-54.26%
21.01.23
21.01.23
Could be very worthwhile Investment >20% year
Evoke Pharma Inc.
Start price
Target price
Perf. (%)
€28.25
21.01.21
21.01.21
€120.00
21.01.23
21.01.23
-86.83%
21.01.23
21.01.23
Could be very worthwhile Investment >20% year
Dare Bioscience Inc.
Start price
Target price
Perf. (%)
€2.50
21.01.21
21.01.21
€10.00
21.01.22
21.01.22
-47.52%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
Lipocine Inc.
Start price
Target price
Perf. (%)
€32.30
21.01.21
21.01.21
€136.00
21.01.22
21.01.22
-57.58%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
Johnson & Johnson
Start price
Target price
Perf. (%)
€134.68
20.01.21
20.01.21
€144.00
0.89%
02.02.21
02.02.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
AstraZeneca plc
Start price
Target price
Perf. (%)
€87.23
20.01.21
20.01.21
-
20.01.22
20.01.22
-1.82%
29.03.21
29.03.21
Small cyclical dependencies
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.31
19.01.21
19.01.21
€67.00
19.01.22
19.01.22
14.53%
20.01.22
20.01.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Formycon AG
Start price
Target price
Perf. (%)
€60.40
18.01.21
18.01.21
€80.00
18.01.22
18.01.22
-9.93%
04.10.21
04.10.21
Could be worthwhile Investment >10% per year